Canopy Growth Corp (CGC) EBITDA
- 2026-06-30: Basis Reported; EBITDA (m); Operating income -22.11M CAD; Depreciation and amortization (m).
- 2025-12-31: Basis Reported; EBITDA (m); Operating income -26.35M CAD; Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA (m); Operating income -16.89M CAD; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA (m); Operating income -22.62M CAD; Depreciation and amortization (m).
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | Reported | (m) | -22.11M CAD | (m) | 81.17M CAD | (m) | 737.00K CAD | -25.01M CAD | 58.93M CAD | (m) | 40.22M CAD | -129.00K CAD |
| 2025-12-31 | Reported | (m) | -26.35M CAD | (m) | 74.54M CAD | (m) | 1.80M CAD* | -17.24M CAD* | 53.08M CAD | (m) | 44.44M CAD | 368.00K CAD |
| 2025-09-30 | Reported | (m) | -16.89M CAD | (m) | 66.68M CAD | (m) | 1.23M CAD* | -17.98M CAD* | 44.78M CAD | (m) | 36.30M CAD | 214.00K CAD |
| 2025-06-30 | Reported | (m) | -22.62M CAD | (m) | 72.13M CAD | (m) | 1.31M CAD | -10.34M CAD | 54.10M CAD | (m) | 38.11M CAD | 291.00K CAD |
| 2024-12-31 | Reported | (m) | -23.82M CAD | (m) | 74.76M CAD | (m) | 1.22M CAD* | -26.97M CAD* | 50.66M CAD | (m) | 41.48M CAD | 316.00K CAD |
| 2024-09-30 | Reported | (m) | -45.94M CAD | (m) | 62.99M CAD | (m) | 2.59M CAD* | -53.85M CAD* | 41.15M CAD | (m) | 41.73M CAD | 302.00K CAD |
| 2024-06-30 | Reported | (m) | -29.11M CAD | (m) | 66.21M CAD | (m) | 3.92M CAD | -51.78M CAD | 43.18M CAD | (m) | 47.97M CAD | 6.19M CAD |
| 2023-12-31 | Reported | (m) | -60.32M CAD | (m) | 78.50M CAD | (m) | 564.00K CAD* | -32.57M CAD* | 50.28M CAD | (m) | 54.44M CAD | -1.08M CAD |
| 2023-09-30 | Reported | (m) | -7.01M CAD | (m) | 69.59M CAD | (m) | 690.00K CAD* | -78.65M CAD* | 46.17M CAD | (m) | 57.61M CAD | 12.82M CAD |
| 2023-06-30 | Reported | (m) | -54.65M CAD | (m) | 76.26M CAD | (m) | 1.95M CAD | -148.67M CAD | 62.50M CAD | (m) | 62.76M CAD | 2.02M CAD |
| 2022-12-31 | Reported | (m) | -112.69M CAD | (m) | 84.85M CAD | (m) | 1.87M CAD* | -143.89M CAD* | 79.62M CAD | (m) | 89.60M CAD | -1.34M CAD |
| 2022-09-30 | Reported | (m) | -149.17M CAD | (m) | 87.94M CAD | (m) | 2.02M CAD* | -133.40M CAD* | 88.55M CAD | (m) | 95.02M CAD | 8.22M CAD |
| 2022-06-30 | Reported | (m) | -1.84B CAD | (m) | 105.92M CAD | (m) | 2.29M CAD | -140.51M CAD | 111.51M CAD | (m) | 103.41M CAD | 3.75M CAD |
| 2021-12-31 | Reported | (m) | -149.96M CAD | (m) | 140.97M CAD | (m) | 962.00K CAD* | -167.38M CAD* | 130.88M CAD | (m) | 116.83M CAD | -183.00K CAD |
| 2021-09-30 | Reported | (m) | -215.36M CAD | (m) | 131.37M CAD | (m) | 15.38M CAD* | -85.97M CAD* | 202.51M CAD | (m) | 125.76M CAD | -3.21M CAD |
| 2021-06-30 | Reported | (m) | -187.71M CAD | (m) | 136.21M CAD | (m) | 20.28M CAD | -165.78M CAD | 108.97M CAD | (m) | 112.57M CAD | 2.90M CAD |
| 2020-12-31 | Reported | (m) | -553.61M CAD | (m) | 152.53M CAD | (m) | 47.78M CAD* | -87.60M CAD* | 127.94M CAD | (m) | 144.08M CAD | -15.60M CAD |
| 2020-09-30 | Reported | (m) | -284.26M CAD | (m) | 135.27M CAD | (m) | 28.65M CAD* | -161.75M CAD* | 109.19M CAD | (m) | 147.25M CAD | 552.00K CAD |
| 2020-06-30 | Reported | (m) | -172.38M CAD | (m) | 110.42M CAD | (m) | 61.55M CAD | -118.55M CAD | 103.92M CAD | (m) | 135.39M CAD | -3.04M CAD |
| 2019-12-31 | Reported | (m) | -192.38M CAD | (m) | 123.76M CAD | (m) | 170.71M CAD* | -189.91M CAD* | 85.56M CAD | (m) | 168.91M CAD | -27.45M CAD |
| 2019-09-30 | Reported | (m) | -270.84M CAD | (m) | 76.61M CAD | (m) | 228.33M CAD* | -213.79M CAD* | 72.97M CAD | (m) | 181.60M CAD | -5.77M CAD |
| 2019-06-30 | Reported | (m) | -214.72M CAD | (m) | 90.48M CAD | (m) | 211.82M CAD | -158.29M CAD | 72.19M CAD | (m) | 145.65M CAD | 10.27M CAD |
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | Reported | (m) | -161.66M CAD | (m) | 284.60M CAD | (m) | 5.33M CAD | -63.81M CAD | 214.93M CAD | 2.61M CAD | 159.98M CAD | 23.00K CAD |
| 2025-03-31 | Reported | (m) | -117.14M CAD | (m) | 269.00M CAD | (m) | 10.81M CAD | -165.75M CAD | 189.48M CAD | 2.74M CAD | 169.63M CAD | 7.14M CAD |
| 2024-03-31 | Reported | (m) | -228.71M CAD | (m) | 297.15M CAD | (m) | 3.45M CAD | -281.95M CAD | 216.26M CAD | 4.61M CAD | 229.43M CAD | 12.33M CAD |
| 2023-03-31 | Reported | (m) | -2.63B CAD | (m) | 333.25M CAD | (m) | 9.11M CAD | -557.55M CAD | 396.78M CAD | 21.72M CAD | 342.52M CAD | -5.73M CAD |
| 2022-03-31 | Reported | (m) | -1.02B CAD | (m) | 475.70M CAD | (m) | 36.68M CAD | -545.81M CAD | 663.11M CAD | 32.26M CAD | 415.44M CAD | -8.95M CAD |
| 2021-03-31 | Reported | (m) | -1.24B CAD | (m) | 546.65M CAD | (m) | 164.50M CAD | -465.73M CAD | 479.69M CAD | 57.58M CAD | 575.39M CAD | -13.14M CAD |
| 2020-03-31 | Reported | (m) | -1.67B CAD | (m) | 398.77M CAD | (m) | 704.94M CAD | -772.63M CAD | 430.46M CAD | 61.81M CAD | 693.74M CAD | -121.61M CAD |
| 2019-03-31 | Reported | (m) | -637.45M CAD | (m) | 226.34M CAD | (m) | 644.46M CAD | -535.03M CAD | 198.10M CAD | 15.24M CAD | 392.25M CAD | 4.11M CAD |
| 2018-03-31 | Reported | (m) | -119.60M CAD | (m) | 77.95M CAD | (m) | 175.96M CAD | -81.51M CAD | 44.96M CAD | 2.05M CAD | 103.48M CAD | -392.00K CAD |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |